The method of embodiment 154, wherein the composition comprises between about 0.01% to about 20% by weight of the cholesterol, about 0.01% to about 15% by weight of the cholesterol, about 0.01% to about 10% by weight of the cholesterol, about 0.01% to about 7% by weight of the cholesterol, about 0.01% to about 5% by weight of the cholesterol, about 0.01% to about 3% by weight of the cholesterol, about 0.01% to about 2% by weight of the cholesterol, or about 0.01% to about 1% by weight of the cholesterol
The -aminoadipic-6-semialdehyde is catabolized to -aminoadipic acid via the action of the NAD + -dependent enzyme, aldehyde dehydrogenase 7 family member A1 (encoded by the ALDH7A1 gene), originally identified as -aminoadipic semialdehyde dehydrogenase (AASA dehydrogenase: AASADH)
And it, for those of you that remember the I Love Lucy, uh, episode with Ethylene Lucy at the chocolate factory, [00:52:00] like, you're gonna have a problem
The goal is balancing therapeutic benefits of tirzepatide with tolerability and patient well-being